Publications

Akincilar SC et al. (2022)

Identification of mechanism of cancer-cell-specific reactivation of hTERT offers therapeutic opportunities for blocking telomerase specifically in human colorectal cancer.

Shin, E.M. et al. (2021)

GREB1 : An evolutionarily conserved protein with a glycosyltransferase domain links ERa glycosylation and stability to cancer.

Akincilar SC et al. (2020)

NAIL: an evolutionarily conserved lncRNA essential for licensing coordinated activation of p38 and NFκB in colitis.

Cildir G et al. (2019)

Genome-wide Analyses of Chromatin State in Human Mast Cells Reveal Molecular Drivers and Mediators of Allergic and Inflammatory Diseases.

Akıncılar SC et al. (2016)

Long-range chromatin interactions drive mutant Tert promoter activation.

Khattar E, Kumar et al. (2016)

Telomerase reverse transcriptase promotes cancer cell proliferation by augmenting tRNA expression.

Li Y et al. (2015)

Non-canonical NFkB signaling and ETS1/2 cooperatively drive mutant TERT promoter activation.

Koh CM et al. (2015)

Telomerase regulates MYC-driven oncogenesis independent of its reverse transcriptase activity.

Ghosh A et al. (2012)

Telomerase directly regulates NFκB dependent transcription.

Wu Z et al. (2010)

ATM and NEMO-dependent ELKS ubiquitination coordinates TAK1-mediated IKK activation in response to genotoxic stress.

Teo H et al. (2010)

Telomere independent Rap1 is an IKK-adaptor and regulates NFΚB-dependent gene expression.

Chew J et al. (2009)

WIP1 phosphatase is a negative regulator of NF-kappaB signalling.

Selected

PUBLICATIONS